HEADER TRANSCRIPTION/DNA 07-NOV-05 2D5V TITLE CRYSTAL STRUCTURE OF HNF-6ALPHA DNA-BINDING DOMAIN IN COMPLEX WITH THE TITLE 2 TTR PROMOTER COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*TP*CP*TP*AP*AP*GP*TP*CP*AP*AP*TP*AP*AP*T)-3'; COMPND 3 CHAIN: C, E; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 5'-D(*AP*TP*TP*AP*TP*TP*GP*AP*CP*TP*TP*AP*GP*A)-3'; COMPND 7 CHAIN: D, F; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: HEPATOCYTE NUCLEAR FACTOR 6; COMPND 11 CHAIN: A, B; COMPND 12 FRAGMENT: RESIDUES 1-156; COMPND 13 SYNONYM: HNF-6, ONE CUT DOMAIN FAMILY MEMBER 1; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES; SOURCE 5 MOL_ID: 3; SOURCE 6 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 7 ORGANISM_COMMON: NORWAY RAT; SOURCE 8 ORGANISM_TAXID: 10116; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS TRANSCRIPTION FACTOR, TRANSCRIPTION-DNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.IYAGUCHI,M.YAO,N.WATANABE,J.NISHIHIRA,I.TANAKA REVDAT 5 13-MAR-24 2D5V 1 REMARK SEQADV REVDAT 4 13-JUL-11 2D5V 1 VERSN REVDAT 3 24-FEB-09 2D5V 1 VERSN REVDAT 2 18-SEP-07 2D5V 1 JRNL REVDAT 1 05-DEC-06 2D5V 0 JRNL AUTH D.IYAGUCHI,M.YAO,N.WATANABE,J.NISHIHIRA,I.TANAKA JRNL TITL DNA RECOGNITION MECHANISM OF THE ONECUT HOMEODOMAIN OF JRNL TITL 2 TRANSCRIPTION FACTOR HNF-6 JRNL REF STRUCTURE V. 15 75 2007 JRNL REFN ISSN 0969-2126 JRNL PMID 17223534 JRNL DOI 10.1016/J.STR.2006.11.004 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 34945 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3865 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2264 REMARK 3 NUCLEIC ACID ATOMS : 1072 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 195 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2D5V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000025024. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97799 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39224 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1,6-HEXANEDIOL, SODIUM ACETATE, COBALT REMARK 280 CHLORIDE, PH 5.2, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B4034 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 DA D 1028 REMARK 465 DG F 2027 REMARK 465 DA F 2028 REMARK 465 ALA A 80 REMARK 465 ALA A 81 REMARK 465 CYS A 82 REMARK 465 LYS A 83 REMARK 465 ARG A 84 REMARK 465 LYS A 85 REMARK 465 GLU A 86 REMARK 465 GLN A 87 REMARK 465 GLU A 88 REMARK 465 HIS A 89 REMARK 465 GLY A 90 REMARK 465 LYS A 91 REMARK 465 ASP A 92 REMARK 465 ARG A 93 REMARK 465 GLY A 94 REMARK 465 ASN A 95 REMARK 465 THR A 96 REMARK 465 PRO A 97 REMARK 465 LYS A 98 REMARK 465 LYS A 99 REMARK 465 TRP A 156 REMARK 465 LEU A 157 REMARK 465 GLU A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 ALA B 80 REMARK 465 ALA B 81 REMARK 465 CYS B 82 REMARK 465 LYS B 83 REMARK 465 ARG B 84 REMARK 465 LYS B 85 REMARK 465 GLU B 86 REMARK 465 GLN B 87 REMARK 465 GLU B 88 REMARK 465 HIS B 89 REMARK 465 GLY B 90 REMARK 465 LYS B 91 REMARK 465 ASP B 92 REMARK 465 ARG B 93 REMARK 465 GLY B 94 REMARK 465 ASN B 95 REMARK 465 THR B 96 REMARK 465 PRO B 97 REMARK 465 LYS B 98 REMARK 465 LYS B 99 REMARK 465 TRP B 156 REMARK 465 LEU B 157 REMARK 465 GLU B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DA C1009 O4' - C1' - N9 ANGL. DEV. = 1.8 DEGREES REMARK 500 DT C1011 O4' - C1' - N1 ANGL. DEV. = 2.7 DEGREES REMARK 500 DG D1027 O4' - C1' - N9 ANGL. DEV. = 1.9 DEGREES REMARK 500 DA E2009 O4' - C1' - N9 ANGL. DEV. = 2.0 DEGREES REMARK 500 DA E2012 O4' - C1' - N9 ANGL. DEV. = 2.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 53 -114.24 -114.11 REMARK 500 LEU A 77 12.67 -68.34 REMARK 500 ARG A 78 16.40 -145.62 REMARK 500 ASP A 154 -113.54 -169.06 REMARK 500 LYS B 53 -103.22 -119.04 REMARK 500 ARG B 101 137.21 34.03 REMARK 500 LEU B 153 -74.65 -15.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT E 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D 3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 4002 DBREF 2D5V A 1 156 UNP P70512 HNF6_RAT 289 444 DBREF 2D5V B 1 156 UNP P70512 HNF6_RAT 289 444 DBREF 2D5V C 1001 1014 PDB 2D5V 2D5V 1001 1014 DBREF 2D5V D 1015 1028 PDB 2D5V 2D5V 1015 1028 DBREF 2D5V E 2001 2014 PDB 2D5V 2D5V 2001 2014 DBREF 2D5V F 2015 2028 PDB 2D5V 2D5V 2015 2028 SEQADV 2D5V LEU A 157 UNP P70512 EXPRESSION TAG SEQADV 2D5V GLU A 158 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS A 159 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS A 160 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS A 161 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS A 162 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS A 163 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS A 164 UNP P70512 EXPRESSION TAG SEQADV 2D5V LEU B 157 UNP P70512 EXPRESSION TAG SEQADV 2D5V GLU B 158 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS B 159 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS B 160 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS B 161 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS B 162 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS B 163 UNP P70512 EXPRESSION TAG SEQADV 2D5V HIS B 164 UNP P70512 EXPRESSION TAG SEQRES 1 C 14 DT DC DT DA DA DG DT DC DA DA DT DA DA SEQRES 2 C 14 DT SEQRES 1 D 14 DA DT DT DA DT DT DG DA DC DT DT DA DG SEQRES 2 D 14 DA SEQRES 1 E 14 DT DC DT DA DA DG DT DC DA DA DT DA DA SEQRES 2 E 14 DT SEQRES 1 F 14 DA DT DT DA DT DT DG DA DC DT DT DA DG SEQRES 2 F 14 DA SEQRES 1 A 164 MET GLU GLU ILE ASN THR LYS GLU VAL ALA GLN ARG ILE SEQRES 2 A 164 THR THR GLU LEU LYS ARG TYR SER ILE PRO GLN ALA ILE SEQRES 3 A 164 PHE ALA GLN ARG VAL LEU CYS ARG SER GLN GLY THR LEU SEQRES 4 A 164 SER ASP LEU LEU ARG ASN PRO LYS PRO TRP SER LYS LEU SEQRES 5 A 164 LYS SER GLY ARG GLU THR PHE ARG ARG MET TRP LYS TRP SEQRES 6 A 164 LEU GLN GLU PRO GLU PHE GLN ARG MET SER ALA LEU ARG SEQRES 7 A 164 LEU ALA ALA CYS LYS ARG LYS GLU GLN GLU HIS GLY LYS SEQRES 8 A 164 ASP ARG GLY ASN THR PRO LYS LYS PRO ARG LEU VAL PHE SEQRES 9 A 164 THR ASP VAL GLN ARG ARG THR LEU HIS ALA ILE PHE LYS SEQRES 10 A 164 GLU ASN LYS ARG PRO SER LYS GLU LEU GLN ILE THR ILE SEQRES 11 A 164 SER GLN GLN LEU GLY LEU GLU LEU SER THR VAL SER ASN SEQRES 12 A 164 PHE PHE MET ASN ALA ARG ARG ARG SER LEU ASP LYS TRP SEQRES 13 A 164 LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 164 MET GLU GLU ILE ASN THR LYS GLU VAL ALA GLN ARG ILE SEQRES 2 B 164 THR THR GLU LEU LYS ARG TYR SER ILE PRO GLN ALA ILE SEQRES 3 B 164 PHE ALA GLN ARG VAL LEU CYS ARG SER GLN GLY THR LEU SEQRES 4 B 164 SER ASP LEU LEU ARG ASN PRO LYS PRO TRP SER LYS LEU SEQRES 5 B 164 LYS SER GLY ARG GLU THR PHE ARG ARG MET TRP LYS TRP SEQRES 6 B 164 LEU GLN GLU PRO GLU PHE GLN ARG MET SER ALA LEU ARG SEQRES 7 B 164 LEU ALA ALA CYS LYS ARG LYS GLU GLN GLU HIS GLY LYS SEQRES 8 B 164 ASP ARG GLY ASN THR PRO LYS LYS PRO ARG LEU VAL PHE SEQRES 9 B 164 THR ASP VAL GLN ARG ARG THR LEU HIS ALA ILE PHE LYS SEQRES 10 B 164 GLU ASN LYS ARG PRO SER LYS GLU LEU GLN ILE THR ILE SEQRES 11 B 164 SER GLN GLN LEU GLY LEU GLU LEU SER THR VAL SER ASN SEQRES 12 B 164 PHE PHE MET ASN ALA ARG ARG ARG SER LEU ASP LYS TRP SEQRES 13 B 164 LEU GLU HIS HIS HIS HIS HIS HIS HET ACT D3002 4 HET ACT E3001 4 HET GOL B4001 6 HET GOL B4002 6 HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 7 ACT 2(C2 H3 O2 1-) FORMUL 9 GOL 2(C3 H8 O3) FORMUL 11 HOH *195(H2 O) HELIX 1 1 ASN A 5 TYR A 20 1 16 HELIX 2 2 PRO A 23 VAL A 31 1 9 HELIX 3 3 SER A 35 ASN A 45 1 11 HELIX 4 4 PRO A 48 LEU A 52 5 5 HELIX 5 5 LYS A 53 SER A 54 5 2 HELIX 6 6 GLY A 55 GLU A 68 1 14 HELIX 7 7 PRO A 69 LEU A 77 1 9 HELIX 8 8 THR A 105 ASN A 119 1 15 HELIX 9 9 SER A 123 GLY A 135 1 13 HELIX 10 10 GLU A 137 ARG A 151 1 15 HELIX 11 11 ASN B 5 TYR B 20 1 16 HELIX 12 12 PRO B 23 VAL B 31 1 9 HELIX 13 13 SER B 35 ASN B 45 1 11 HELIX 14 14 PRO B 48 LEU B 52 5 5 HELIX 15 15 LYS B 53 SER B 54 5 2 HELIX 16 16 GLY B 55 GLU B 68 1 14 HELIX 17 17 PRO B 69 LEU B 77 1 9 HELIX 18 18 THR B 105 ASN B 119 1 15 HELIX 19 19 SER B 123 GLY B 135 1 13 HELIX 20 20 GLU B 137 LEU B 153 1 17 SITE 1 AC1 7 ARG B 101 HOH B4010 HOH E 187 DA E2010 SITE 2 AC1 7 DT E2011 DT F2020 DG F2021 SITE 1 AC2 5 PHE A 144 ASN A 147 ARG A 151 DT D1020 SITE 2 AC2 5 DG D1021 SITE 1 AC3 7 HIS B 113 PHE B 144 ASN B 147 ALA B 148 SITE 2 AC3 7 ARG B 151 DT F2020 DG F2021 SITE 1 AC4 6 PRO A 69 PHE A 71 HOH A 173 ASP B 106 SITE 2 AC4 6 VAL B 107 ARG B 110 CRYST1 73.020 38.958 106.500 90.00 107.63 90.00 P 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013695 0.000000 0.004352 0.00000 SCALE2 0.000000 0.025669 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009852 0.00000